Atria Investments Inc Cuts Position in HealthEquity, Inc. (NASDAQ:HQY)

Atria Investments Inc reduced its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 19.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,031 shares of the company’s stock after selling 2,190 shares during the period. Atria Investments Inc’s holdings in HealthEquity were worth $739,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of HQY. Janney Montgomery Scott LLC grew its holdings in shares of HealthEquity by 27.4% in the first quarter. Janney Montgomery Scott LLC now owns 3,970 shares of the company’s stock valued at $324,000 after purchasing an additional 855 shares in the last quarter. US Bancorp DE raised its stake in shares of HealthEquity by 4.8% in the first quarter. US Bancorp DE now owns 11,489 shares of the company’s stock valued at $938,000 after acquiring an additional 521 shares in the last quarter. State Board of Administration of Florida Retirement System boosted its holdings in HealthEquity by 11.1% in the first quarter. State Board of Administration of Florida Retirement System now owns 26,663 shares of the company’s stock valued at $2,177,000 after purchasing an additional 2,660 shares during the period. Vanguard Group Inc. grew its stake in HealthEquity by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock worth $715,783,000 after purchasing an additional 149,133 shares in the last quarter. Finally, Ontario Teachers Pension Plan Board purchased a new stake in HealthEquity during the 1st quarter worth about $363,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HQY. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. JMP Securities restated a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. The Goldman Sachs Group initiated coverage on shares of HealthEquity in a research note on Friday. They set a “neutral” rating and a $108.00 target price for the company. Barrington Research restated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research note on Friday, September 20th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $107.23.

Insider Buying and Selling at HealthEquity

In other news, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now directly owns 3,784 shares of the company’s stock, valued at $363,642.40. This represents a 21.54 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is owned by corporate insiders.

HealthEquity Trading Up 3.5 %

Shares of HQY stock opened at $102.40 on Tuesday. HealthEquity, Inc. has a twelve month low of $62.10 and a twelve month high of $103.12. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The business’s 50 day moving average is $85.54 and its two-hundred day moving average is $81.25. The company has a market capitalization of $8.94 billion, a P/E ratio of 85.33, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.16. The company had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. Equities analysts forecast that HealthEquity, Inc. will post 2.27 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.